Stocks
Century Therapeutics, Inc.IPSC
NASDAQHealthcareBiotechnology$1.37
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for cancer and other diseases. Its pipeline focuses on allogeneic, off-the-shelf CAR-iT and CAR-NK products, which investors track for their potential to improve upon autologous cell therapies. The company is headquartered in Philadelphia and listed on Nasdaq under the ticker IPSC.
52W Range: $0.43-$3.04
Congressional Interest in Century Therapeutics, Inc. (IPSC)
No congressional trades have been disclosed for Century Therapeutics, Inc. (IPSC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IPSC?
No congressional trades found for this stock.